A Phase 1/2, open-label, multi-arm study, of AGEN1884 in combination with AGEN2034 in subjects with cervical cancer

Type of Cancer

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Phase 1/2, open-label, multi-arm study, of AGEN1884 in combination with AGEN2034 in subjects with cervical cancer

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.